Table of Contents

Global Abiraterone Acetate API Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Abiraterone Acetate API Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Abiraterone Acetate API Market Size Growth Rate by Type
  • 1.4.2 Purity ≥ 98 %
  • 1.4.3 Purity ≥ 99 %
• 1.5 Market by Application
  • 1.5.1 Global Abiraterone Acetate API Market Size Growth Rate by Application
  • 1.5.2 Abiraterone Acetate Tablets
  • 1.5.3 Abiraterone Acetate Capsules
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Abiraterone Acetate API Production
  • 2.1.1 Global Abiraterone Acetate API Revenue 2014-2025
  • 2.1.2 Global Abiraterone Acetate API Production 2014-2025
  • 2.1.3 Global Abiraterone Acetate API Capacity 2014-2025
  • 2.1.4 Global Abiraterone Acetate API Marketing Pricing and Trends
• 2.2 Abiraterone Acetate API Growth Rate (CAGR) 2019-2025
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Key Abiraterone Acetate API Manufacturers
    • 2.3.2.1 Abiraterone Acetate API Manufacturing Base Distribution, Headquarters
    • 2.3.2.2 Manufacturers Abiraterone Acetate API Product Offered
    • 2.3.2.3 Date of Manufacturers Enter into Abiraterone Acetate API Market
• 2.4 Market Drivers, Trends and Issues

3 Market Size by Manufacturers

• 3.1 Abiraterone Acetate API Production by Manufacturers
  • 3.1.1 Abiraterone Acetate API Production by Manufacturers
  • 3.1.2 Abiraterone Acetate API Production Market Share by Manufacturers
  • 3.1.3 Global Market Concentration Ratio (CR5 and HHI)
• 3.2 Abiraterone Acetate API Revenue by Manufacturers
  • 3.2.1 Abiraterone Acetate API Revenue by Manufacturers (2014-2019)
  • 3.2.2 Abiraterone Acetate API Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Abiraterone Acetate API Market Concentration Ratio (CR10 and HHI)
• 3.3 Abiraterone Acetate API Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Abiraterone Acetate API Production by Regions

• 4.1 Global Abiraterone Acetate API Production by Regions
  • 4.1.1 Global Abiraterone Acetate API Production Market Share by Regions
  • 4.1.2 Global Abiraterone Acetate API Revenue Market Share by Regions
• 4.2 North America
  • 4.2.1 North America Abiraterone Acetate API Production
  • 4.2.2 North America Abiraterone Acetate API Revenue
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Abiraterone Acetate API Import & Export
• 4.3 Europe
  • 4.3.1 Europe Abiraterone Acetate API Production
  • 4.3.2 Europe Abiraterone Acetate API Revenue
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Abiraterone Acetate API Import & Export
• 4.4 China
  • 4.4.1 China Abiraterone Acetate API Production
  • 4.4.2 China Abiraterone Acetate API Revenue
  • 4.4.3 Key Players in China
  • 4.4.4 China Abiraterone Acetate API Import & Export
• 4.5 Japan
  • 4.5.1 Japan Abiraterone Acetate API Production
  • 4.5.2 Japan Abiraterone Acetate API Revenue
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Abiraterone Acetate API Import & Export

5 Abiraterone Acetate API Consumption by Regions

• 5.1 Global Abiraterone Acetate API Consumption by Regions
  • 5.1.1 Global Abiraterone Acetate API Consumption by Regions
  • 5.1.2 Global Abiraterone Acetate API Consumption Market Share by Regions
• 5.2 North America
  • 5.2.1 North America Abiraterone Acetate API Consumption by Application
  • 5.2.2 North America Abiraterone Acetate API Consumption by Countries
  • 5.2.3 United States
  • 5.2.4 Canada
  • 5.2.5 Mexico
• 5.3 Europe
  • 5.3.1 Europe Abiraterone Acetate API Consumption by Application
  • 5.3.2 Europe Abiraterone Acetate API Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 UK
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Abiraterone Acetate API Consumption by Application
  • 5.4.2 Asia Pacific Abiraterone Acetate API Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Indonesia
  • 5.4.9 Thailand
  • 5.4.10 Malaysia
  • 5.4.11 Philippines
  • 5.4.12 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Abiraterone Acetate API Consumption by Application
  • 5.5.2 Central & South America Abiraterone Acetate API Consumption by Countries
  • 5.5.3 Brazil
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Abiraterone Acetate API Consumption by Application
  • 5.6.2 Middle East and Africa Abiraterone Acetate API Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 GCC Countries
  • 5.6.5 Egypt
  • 5.6.6 South Africa

6 Market Size by Type

• 6.1 Global Abiraterone Acetate API Breakdown Dada by Type
• 6.2 Global Abiraterone Acetate API Revenue by Type
• 6.3 Abiraterone Acetate API Price by Type

7 Market Size by Application

• 7.1 Overview
• 7.2 Global Abiraterone Acetate API Breakdown Dada by Application
  • 7.2.1 Global Abiraterone Acetate API Consumption by Application
  • 7.2.2 Global Abiraterone Acetate API Consumption Market Share by Application (2014-2019)

8 Manufacturers Profiles

• 8.1 Cipla
  • 8.1.1 Cipla Company Details
  • 8.1.2 Company Description
  • 8.1.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.1.4 Abiraterone Acetate API Product Description
  • 8.1.5 SWOT Analysis
• 8.2 Sterling S.P.A. IT
  • 8.2.1 Sterling S.P.A. IT Company Details
  • 8.2.2 Company Description
  • 8.2.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.2.4 Abiraterone Acetate API Product Description
  • 8.2.5 SWOT Analysis
• 8.3 Scion Pharm Taiwan
  • 8.3.1 Scion Pharm Taiwan Company Details
  • 8.3.2 Company Description
  • 8.3.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.3.4 Abiraterone Acetate API Product Description
  • 8.3.5 SWOT Analysis
• 8.4 HETERO
  • 8.4.1 HETERO Company Details
  • 8.4.2 Company Description
  • 8.4.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.4.4 Abiraterone Acetate API Product Description
  • 8.4.5 SWOT Analysis
• 8.5 Aspen Bio Pharma Labs
  • 8.5.1 Aspen Bio Pharma Labs Company Details
  • 8.5.2 Company Description
  • 8.5.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.5.4 Abiraterone Acetate API Product Description
  • 8.5.5 SWOT Analysis
• 8.6 Aurisco Pharmaceutical
  • 8.6.1 Aurisco Pharmaceutical Company Details
  • 8.6.2 Company Description
  • 8.6.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.6.4 Abiraterone Acetate API Product Description
  • 8.6.5 SWOT Analysis
• 8.7 Farmhispania Group
  • 8.7.1 Farmhispania Group Company Details
  • 8.7.2 Company Description
  • 8.7.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.7.4 Abiraterone Acetate API Product Description
  • 8.7.5 SWOT Analysis
• 8.8 Tapi Teva
  • 8.8.1 Tapi Teva Company Details
  • 8.8.2 Company Description
  • 8.8.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.8.4 Abiraterone Acetate API Product Description
  • 8.8.5 SWOT Analysis
• 8.9 Shilpa Medicare Limited
  • 8.9.1 Shilpa Medicare Limited Company Details
  • 8.9.2 Company Description
  • 8.9.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.9.4 Abiraterone Acetate API Product Description
  • 8.9.5 SWOT Analysis
• 8.10 Qilu Pharmaceutial
  • 8.10.1 Qilu Pharmaceutial Company Details
  • 8.10.2 Company Description
  • 8.10.3 Capacity, Production and Value of Abiraterone Acetate API
  • 8.10.4 Abiraterone Acetate API Product Description
  • 8.10.5 SWOT Analysis
• 8.11 Shandong Chuangxin Pharmaceutical Research and Development
• 8.12 Zhejiang Xianju Junye Pharmaceutical
• 8.13 Wuhan Sunrise Technology Development

9 Production Forecasts

• 9.1 Abiraterone Acetate API Production and Revenue Forecast
  • 9.1.1 Global Abiraterone Acetate API Production Forecast 2019-2025
  • 9.1.2 Global Abiraterone Acetate API Revenue Forecast 2019-2025
• 9.2 Abiraterone Acetate API Production and Revenue Forecast by Regions
  • 9.2.1 Global Abiraterone Acetate API Revenue Forecast by Regions
  • 9.2.2 Global Abiraterone Acetate API Production Forecast by Regions
• 9.3 Abiraterone Acetate API Key Producers Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan
• 9.4 Forecast by Type
  • 9.4.1 Global Abiraterone Acetate API Production Forecast by Type
  • 9.4.2 Global Abiraterone Acetate API Revenue Forecast by Type

10 Consumption Forecast

• 10.1 Consumption Forecast by Application
• 10.2 Abiraterone Acetate API Consumption Forecast by Regions
• 10.3 North America Market Consumption Forecast
  • 10.3.1 North America Abiraterone Acetate API Consumption Forecast by Countries 2019-2025
  • 10.3.2 United States
  • 10.3.3 Canada
  • 10.3.4 Mexico
• 10.4 Europe Market Consumption Forecast
  • 10.4.1 Europe Abiraterone Acetate API Consumption Forecast by Countries 2019-2025
  • 10.4.2 Germany
  • 10.4.3 France
  • 10.4.4 UK
  • 10.4.5 Italy
  • 10.4.6 Russia
• 10.5 Asia Pacific Market Consumption Forecast
  • 10.5.1 Asia Pacific Abiraterone Acetate API Consumption Forecast by Regions 2019-2025
  • 10.5.2 China
  • 10.5.3 Japan
  • 10.5.4 South Korea
  • 10.5.5 India
  • 10.5.6 Australia
  • 10.5.7 Indonesia
  • 10.5.8 Thailand
  • 10.5.9 Malaysia
  • 10.5.10 Philippines
  • 10.5.11 Vietnam
• 10.6 Central & South America Market Consumption Forecast
  • 10.6.1 Central & South America Abiraterone Acetate API Consumption Forecast by Country 2019-2025
  • 10.6.2 Brazil
• 10.7 Middle East and Africa Market Consumption Forecast
  • 10.7.1 Middle East and Africa Abiraterone Acetate API Consumption Forecast by Countries 2019-2025
  • 10.7.2 Turkey
  • 10.7.3 GCC Countries
  • 10.7.4 Egypt
  • 10.7.5 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis

• 11.1 Analysis of Abiraterone Acetate API Upstream Market
  • 11.1.1 Abiraterone Acetate API Key Raw Material
  • 11.1.2 Typical Suppliers of Key Abiraterone Acetate API Raw Material
  • 11.1.3 Abiraterone Acetate API Raw Material Market Concentration Rate
• 11.2 Abiraterone Acetate API Industry Chain Analysis
• 11.3 Marketing & Distribution
• 11.4 Abiraterone Acetate API Distributors
• 11.5 Abiraterone Acetate API Customers

12 Opportunities & Challenges, Threat and Affecting Factors

• 12.1 Market Opportunities
• 12.2 Market Challenges
• 12.3 Porter's Five Forces Analysis

13 Key Findings

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

This report researches the worldwide Abiraterone Acetate API market size (value, capacity, production and consumption) in key regions like North America, Europe, China and Japan.
This study categorizes the global Abiraterone Acetate API breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Cipla
Sterling S.P.A. IT
Scion Pharm Taiwan
HETERO
Aspen Bio Pharma Labs
Aurisco Pharmaceutical
Farmhispania Group
Tapi Teva
Shilpa Medicare Limited
Qilu Pharmaceutial
Shandong Chuangxin Pharmaceutical Research and Development
Zhejiang Xianju Junye Pharmaceutical
Wuhan Sunrise Technology Development

Abiraterone Acetate API Breakdown Data by Type
Purity ≥ 98 %
Purity ≥ 99 %

Abiraterone Acetate API Breakdown Data by Application
Abiraterone Acetate Tablets
Abiraterone Acetate Capsules
Others

Abiraterone Acetate API Production Breakdown Data by Region
North America
Europe
China
Japan

Abiraterone Acetate API Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Abiraterone Acetate API capacity, production, value, consumption, status and forecast;
To focus on the key Abiraterone Acetate API manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Abiraterone Acetate API :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.